Ruggie Capital Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

Ruggie Capital Group’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,733	Closed	-$272K	–	182
2016 Q3	$272K	Hold	4,733	–	–	0.24%	46
2016 Q2	$277K	Hold	4,733	–	–	0.25%	43
2016 Q1	$272K	Buy	+4,733	New	+$280K	0.28%	34
2015 Q4	–	Sell	-4,733	Closed	-$301K	–	133
2015 Q3	$301K	Sell	4,733 -1,082	-19%	-$76K	0.29%	39
2015 Q2	$356K	Buy	5,815 +1,082	+23%	+$77.9K	0.29%	33
2015 Q1	$332K	Buy	4,733 +1,128	+31%	+$76.5K	0.4%	31
2014 Q4	$232K	Buy	+3,605	New	+$230K	0.21%	41

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Colrain Capital Boston, Massachusetts $259M AUM 63.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SCM

Stuyvesant Capital Management Armonk, New York $41.1M AUM 17.11% 1-Year Est. Return

Ruggie Capital Group's PPH Position: Q4 2016 in Review

Ruggie Capital Group sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2016, closing a stake of 4,733 shares — an estimated $272K sold.

Ruggie Capital Group first reported a position in PPH in Q4 2014 and held it in 7 quarters. The position peaked at $356K in Q2 2015. 51 funds tracked by Wall St. Rank hold PPH as of Q4 2016.

Ruggie Capital Group reported no remaining VanEck Pharmaceutical ETF position as of Q4 2016 after selling out during the quarter.
Ruggie Capital Group sold 4,733 VanEck Pharmaceutical ETF shares in Q4 2016, an estimated $272K.
Ruggie Capital Group first reported a position in VanEck Pharmaceutical ETF in Q4 2014 and held it in 7 quarters.
Ruggie Capital Group's VanEck Pharmaceutical ETF position peaked at $356K in Q2 2015.
51 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2016.

Based on Ruggie Capital Group's 13F filing for Q4 2016, filed 30 Jan 2017.